Giansiracusa Richard MD Loveland, CO - 80537

Giansiracusa Richard MD is categorized under Specialty Outpatient Clinics, Nec in Loveland, CO .

Giansiracusa Richard MD was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Specialty Outpatient Clinics, Nec business, which does work in the B2C market, and is classified as a Specialty Outpatient Clinics, Nec, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Richard Giansiracusa at the company’s single location by writing to 2555 East 13th St # 100, Loveland, Colorado CO 80537 or by phoning (970) 613-1745. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Giansiracusa Richard MD
Contact Person: Richard Giansiracusa
Address: 2555 East 13th St # 100, Loveland, Colorado 80537
Phone Number: (970) 613-1745
Website Address: bannerhealth.com
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Specialty Outpatient Clinics, Nec
SIC Code: 8093
NAICS Code: 6211110
Share This Business:

Giansiracusa Richard MD was started in 0 to provide professional Specialty Outpatient Clinics, Nec under the SIC code 8093 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Richard Giansiracusa for inquiries that concern Giansiracusa Richard MD by calling the company number (970) 613-1745, as your correspondence is most welcome. Additionally, the physical location of the single location of Giansiracusa Richard MD can be found at the coordinates 40.40522,-105.04127 as well as the street address 2555 East 13th St # 100 in Loveland, Colorado 80537.

For its online presence, you may visit Giansiracusa Richard MD’s website at bannerhealth.com and engage with its social media outlets through on Twitter and on Facebook.